R1 RCM (RCM) Set to Announce Quarterly Earnings on Wednesday

R1 RCM (NASDAQ:RCM) is scheduled to be releasing its earnings data before the market opens on Wednesday, May 8th. Analysts expect R1 RCM to post earnings of ($0.05) per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

R1 RCM Stock Performance

Shares of R1 RCM stock opened at $12.76 on Tuesday. The company’s 50 day moving average price is $12.98 and its 200-day moving average price is $11.43. R1 RCM has a 52-week low of $8.87 and a 52-week high of $18.70. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.83 and a current ratio of 1.83.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. SVB Leerink started coverage on shares of R1 RCM in a research report on Monday, February 26th. They set an “outperform” rating and a $14.00 price objective on the stock. Evercore ISI reissued an “in-line” rating and issued a $16.00 price target (up from $12.00) on shares of R1 RCM in a research note on Wednesday, February 28th. KeyCorp reaffirmed a “sector weight” rating on shares of R1 RCM in a research report on Wednesday, April 10th. Morgan Stanley reiterated an “overweight” rating and set a $17.00 target price on shares of R1 RCM in a report on Tuesday, March 26th. Finally, Truist Financial restated a “hold” rating and issued a $16.00 target price on shares of R1 RCM in a research note on Monday, April 1st. Five analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $16.87.

Insider Buying and Selling at R1 RCM

In other R1 RCM news, President John M. Sparby sold 10,046 shares of the company’s stock in a transaction that occurred on Thursday, March 7th. The shares were sold at an average price of $14.33, for a total transaction of $143,959.18. Following the completion of the sale, the president now directly owns 265,986 shares of the company’s stock, valued at $3,811,579.38. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 36.80% of the company’s stock.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.